The global Peripheral Vascular Devices Market is witnessing substantial growth due to the increasing prevalence of peripheral artery disease (PAD), rising adoption of minimally invasive procedures, and continuous technological advancements in vascular intervention technologies. Peripheral vascular devices are widely used to restore blood flow in arteries and veins outside the heart, especially in the legs and arms, helping prevent complications such as limb ischemia, aneurysms, and venous disorders.
The global peripheral vascular devices market size was valued at USD 12.04 billion in 2025 and is projected to grow from USD 12.62 billion in 2026 to USD 19.42 billion by 2034, exhibiting a CAGR of 5.5% during the forecast period.
One of the major growth factors for the peripheral vascular devices market is the growing incidence of peripheral artery disease and other circulatory disorders worldwide. Sedentary lifestyles, obesity, diabetes, smoking, and hypertension are significantly contributing to vascular complications, increasing the demand for advanced treatment devices.
Healthcare providers are increasingly adopting minimally invasive vascular procedures because they reduce hospital stays, recovery time, and surgical complications. As a result, the demand for stents, guidewires, catheters, thrombectomy devices, and vascular imaging systems continues to rise globally.
The market is experiencing rapid technological evolution with the introduction of drug-eluting stents, bioresorbable scaffolds, advanced imaging systems, and improved embolus management devices. Companies are investing heavily in research and development to improve procedural accuracy and patient outcomes.
Recent product approvals are accelerating innovation across the industry. For instance, Abbott received FDA approval for its Esprit BTK Everolimus-eluting resorbable scaffold system designed for lower leg blood flow restoration. Additionally, Philips launched its Duo Venous Stent System for venous outflow obstruction treatment.
Growing focus on below-the-knee (BTK) interventions for diabetic patients with complex vascular conditions is also creating new opportunities for manufacturers and healthcare providers.
Based on product type, the peripheral stents segment holds the largest market share owing to its effectiveness in treating narrowed or blocked arteries. Peripheral stents provide improved blood circulation and long-term vessel support, making them highly preferred in hospitals and specialty clinics.
The thrombus and embolus management devices segment is also expected to witness significant growth during the forecast period due to rising cases of blood clot-related vascular complications.
Hospitals account for the largest share of the peripheral vascular devices market because most vascular procedures require advanced imaging systems, specialized healthcare professionals, and post-operative monitoring facilities. Hospitals are also among the earliest adopters of innovative endovascular technologies.
Specialty clinics are expected to witness notable growth as outpatient vascular procedures continue to increase worldwide.
North America dominates the global peripheral vascular devices market due to advanced healthcare infrastructure, rising prevalence of diabetes and cardiovascular diseases, and strong adoption of minimally invasive procedures. The U.S. remains the largest contributor to regional growth.
Meanwhile, the Asia Pacific region is anticipated to register strong growth during the forecast period due to improving healthcare infrastructure, increasing awareness regarding vascular disorders, and rising healthcare spending in countries such as China, India, and Japan.
The market is moderately consolidated with several global medical device manufacturers focusing on innovation, partnerships, acquisitions, and regulatory approvals to strengthen their market positions.
Key companies operating in the market include:
Abbott
Medtronic
Boston Scientific Corporation
Terumo Corporation
BD
Cook Medical
Cardinal Health
Teleflex Incorporated
Merit Medical Systems
Getinge AB
Companies are increasingly focusing on acquisitions and product innovation to enhance their vascular intervention portfolios and strengthen their global presence.
The future of the peripheral vascular devices market appears highly promising due to the rising burden of vascular diseases, expanding geriatric population, and growing preference for minimally invasive interventions. Technological innovations in vascular imaging, bioresorbable stents, and catheter-based procedures are expected to further accelerate market growth over the coming years.
Increased healthcare investments, favorable reimbursement policies, and growing awareness regarding early diagnosis and treatment of peripheral vascular disorders are likely to create lucrative opportunities for market participants worldwide.
The global Peripheral Vascular Devices Market is witnessing substantial growth due to the increasing prevalence of peripheral artery disease (PAD), rising adoption of minimally invasive procedures, and continuous technological advancements in vascular intervention technologies. Peripheral vascular devices are widely used to restore blood flow in arteries and veins outside the heart, especially in the legs and arms, helping prevent complications such as limb ischemia, aneurysms, and venous disorders.
The global peripheral vascular devices market size was valued at USD 12.04 billion in 2025 and is projected to grow from USD 12.62 billion in 2026 to USD 19.42 billion by 2034, exhibiting a CAGR of 5.5% during the forecast period.
One of the major growth factors for the peripheral vascular devices market is the growing incidence of peripheral artery disease and other circulatory disorders worldwide. Sedentary lifestyles, obesity, diabetes, smoking, and hypertension are significantly contributing to vascular complications, increasing the demand for advanced treatment devices.
Healthcare providers are increasingly adopting minimally invasive vascular procedures because they reduce hospital stays, recovery time, and surgical complications. As a result, the demand for stents, guidewires, catheters, thrombectomy devices, and vascular imaging systems continues to rise globally.
The market is experiencing rapid technological evolution with the introduction of drug-eluting stents, bioresorbable scaffolds, advanced imaging systems, and improved embolus management devices. Companies are investing heavily in research and development to improve procedural accuracy and patient outcomes.
Recent product approvals are accelerating innovation across the industry. For instance, Abbott received FDA approval for its Esprit BTK Everolimus-eluting resorbable scaffold system designed for lower leg blood flow restoration. Additionally, Philips launched its Duo Venous Stent System for venous outflow obstruction treatment.
Growing focus on below-the-knee (BTK) interventions for diabetic patients with complex vascular conditions is also creating new opportunities for manufacturers and healthcare providers.
Based on product type, the peripheral stents segment holds the largest market share owing to its effectiveness in treating narrowed or blocked arteries. Peripheral stents provide improved blood circulation and long-term vessel support, making them highly preferred in hospitals and specialty clinics.
The thrombus and embolus management devices segment is also expected to witness significant growth during the forecast period due to rising cases of blood clot-related vascular complications.
Hospitals account for the largest share of the peripheral vascular devices market because most vascular procedures require advanced imaging systems, specialized healthcare professionals, and post-operative monitoring facilities. Hospitals are also among the earliest adopters of innovative endovascular technologies.
Specialty clinics are expected to witness notable growth as outpatient vascular procedures continue to increase worldwide.
North America dominates the global peripheral vascular devices market due to advanced healthcare infrastructure, rising prevalence of diabetes and cardiovascular diseases, and strong adoption of minimally invasive procedures. The U.S. remains the largest contributor to regional growth.
Meanwhile, the Asia Pacific region is anticipated to register strong growth during the forecast period due to improving healthcare infrastructure, increasing awareness regarding vascular disorders, and rising healthcare spending in countries such as China, India, and Japan.
The market is moderately consolidated with several global medical device manufacturers focusing on innovation, partnerships, acquisitions, and regulatory approvals to strengthen their market positions.
Key companies operating in the market include:
Abbott
Medtronic
Boston Scientific Corporation
Terumo Corporation
BD
Cook Medical
Cardinal Health
Teleflex Incorporated
Merit Medical Systems
Getinge AB
Companies are increasingly focusing on acquisitions and product innovation to enhance their vascular intervention portfolios and strengthen their global presence.
The future of the peripheral vascular devices market appears highly promising due to the rising burden of vascular diseases, expanding geriatric population, and growing preference for minimally invasive interventions. Technological innovations in vascular imaging, bioresorbable stents, and catheter-based procedures are expected to further accelerate market growth over the coming years.
Increased healthcare investments, favorable reimbursement policies, and growing awareness regarding early diagnosis and treatment of peripheral vascular disorders are likely to create lucrative opportunities for market participants worldwide.
The global Peripheral Vascular Devices Market is witnessing substantial growth due to the increasing prevalence of peripheral artery disease (PAD), rising adoption of minimally invasive procedures, and continuous technological advancements in vascular intervention technologies. Peripheral vascular devices are widely used to restore blood flow in arteries and veins outside the heart, especially in the legs and arms, helping prevent complications such as limb ischemia, aneurysms, and venous disorders.
The global peripheral vascular devices market size was valued at USD 12.04 billion in 2025 and is projected to grow from USD 12.62 billion in 2026 to USD 19.42 billion by 2034, exhibiting a CAGR of 5.5% during the forecast period.
One of the major growth factors for the peripheral vascular devices market is the growing incidence of peripheral artery disease and other circulatory disorders worldwide. Sedentary lifestyles, obesity, diabetes, smoking, and hypertension are significantly contributing to vascular complications, increasing the demand for advanced treatment devices.
Healthcare providers are increasingly adopting minimally invasive vascular procedures because they reduce hospital stays, recovery time, and surgical complications. As a result, the demand for stents, guidewires, catheters, thrombectomy devices, and vascular imaging systems continues to rise globally.
The market is experiencing rapid technological evolution with the introduction of drug-eluting stents, bioresorbable scaffolds, advanced imaging systems, and improved embolus management devices. Companies are investing heavily in research and development to improve procedural accuracy and patient outcomes.
Recent product approvals are accelerating innovation across the industry. For instance, Abbott received FDA approval for its Esprit BTK Everolimus-eluting resorbable scaffold system designed for lower leg blood flow restoration. Additionally, Philips launched its Duo Venous Stent System for venous outflow obstruction treatment.
Growing focus on below-the-knee (BTK) interventions for diabetic patients with complex vascular conditions is also creating new opportunities for manufacturers and healthcare providers.
Based on product type, the peripheral stents segment holds the largest market share owing to its effectiveness in treating narrowed or blocked arteries. Peripheral stents provide improved blood circulation and long-term vessel support, making them highly preferred in hospitals and specialty clinics.
The thrombus and embolus management devices segment is also expected to witness significant growth during the forecast period due to rising cases of blood clot-related vascular complications.
Hospitals account for the largest share of the peripheral vascular devices market because most vascular procedures require advanced imaging systems, specialized healthcare professionals, and post-operative monitoring facilities. Hospitals are also among the earliest adopters of innovative endovascular technologies.
Specialty clinics are expected to witness notable growth as outpatient vascular procedures continue to increase worldwide.
North America dominates the global peripheral vascular devices market due to advanced healthcare infrastructure, rising prevalence of diabetes and cardiovascular diseases, and strong adoption of minimally invasive procedures. The U.S. remains the largest contributor to regional growth.
Meanwhile, the Asia Pacific region is anticipated to register strong growth during the forecast period due to improving healthcare infrastructure, increasing awareness regarding vascular disorders, and rising healthcare spending in countries such as China, India, and Japan.
The market is moderately consolidated with several global medical device manufacturers focusing on innovation, partnerships, acquisitions, and regulatory approvals to strengthen their market positions.
Key companies operating in the market include:
Abbott
Medtronic
Boston Scientific Corporation
Terumo Corporation
BD
Cook Medical
Cardinal Health
Teleflex Incorporated
Merit Medical Systems
Getinge AB
Companies are increasingly focusing on acquisitions and product innovation to enhance their vascular intervention portfolios and strengthen their global presence.
The future of the peripheral vascular devices market appears highly promising due to the rising burden of vascular diseases, expanding geriatric population, and growing preference for minimally invasive interventions. Technological innovations in vascular imaging, bioresorbable stents, and catheter-based procedures are expected to further accelerate market growth over the coming years.
Increased healthcare investments, favorable reimbursement policies, and growing awareness regarding early diagnosis and treatment of peripheral vascular disorders are likely to create lucrative opportunities for market participants worldwide.